Merck KGaA (XTER:MRK)
€ 155.5 -0.2 (-0.13%) Market Cap: 67.61 Bil Enterprise Value: 75.46 Bil PE Ratio: 23.96 PB Ratio: 2.53 GF Score: 89/100

Q2 2023 Merck KGaA Earnings Call Transcript

Aug 03, 2023 / 12:00PM GMT
Release Date Price: €164.1 (+3.18%)
Operator

Dear ladies and gentlemen, welcome to the Merck Investor and Analyst Conference Call on the Second Quarter 2023. (Operator Instructions) I will now hand over to Constantin Fest, Head of Investor Relations, who will lead you through this conference. Please go ahead, sir.

Constantin Fest
Merck KGaA - Head of IR

Thank you very much, Sharon. A very warm welcome to this Merck Q2 2023 Results Call. My name is Constantin Fest, I'm Head of Investor Relations here at Merck. I'm delighted to be joined today by Belén Garijo, CEO of the Group; as well as Helene von Roeder, Group CFO. Also, for the Q&A part of this call will be joined by Matthias Heinzel, CEO of Life Science; Peter Guenter, CEO of Healthcare; and Kai Beckmann, CEO of Electronics.

In the next couple of minutes, we'd like to run you through the key slides of the presentation, and after that, we'll have our Q&A. Also note that we've reserved about roughly 1 hour for this conference call as some of us will have to catch a plane due to road shows.

With this, I'd like to now hand over

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot